Compound atlas
Growth

Ipamorelin

Peptide
Half-life
2h
approx. mean t½
Dose range
200–300 mcg
typical, not prescriptive
Category
Growth
primary use-case
Single-dose decay
t½ = 2h · first-order model
~8h
to clear
1× t½
50%
remaining
2× t½
25%
remaining
~4× t½
6%
remaining
0%25%50%75%100%0m2h4h6h8h10h

How a single dose clears, assuming first-order elimination. The half-life is the biggest driver of how often you dose — start a cycle to see your own cumulative concentration curve.

Overview

A selective ghrelin-receptor agonist that triggers GH release without raising cortisol or prolactin. Cleaner profile than older GHRPs.

Mechanism of action

Selectively binds GHS-R1a (the ghrelin receptor) on the pituitary for pulsatile, biomimetic GH release.

Typical protocol

200–300 mcg subQ, 1–3× daily, ideally on an empty stomach.

Storage

Reconstituted: refrigerated, ~30 days.

Disclaimer

This page summarizes publicly available information. None of it constitutes medical advice, prescription, or recommendation to acquire, possess, or use any compound. Many peptides described are research chemicals not approved for human use in the EU. Consult a licensed physician.